The findings of our study indicated a statistically significant increase in the median expression levels of DDIT4 in patients with moderate/poor tumor differentiation in comparison to those with well-differentiated tumors (P = 0.015) (Fig. 2C). Here, DDIT4 is linked to neoplasm.